Sonavex’s multidisciplinary team of surgeons, scientists, technologists and business leaders brings decades of experience in developing, commercializing, and scaling novel medical technologies
About Sonavex
Rethinking ultrasound
Surgical ultrasound is
Our Mission
Sonavex builds automated ultrasound solutions to quantify and visualize critical clinical data for surgeons who need reliable information on-demand.
Interdisciplinary collaboration
Technologies created by surgeons
Winner of numerous industry awards
Research supported by federal and state agencies
Our Team
-
David Narrow
Chief Executive OfficerMr. Narrow previously worked with multinational medical device companies to commercialize their technologies and provide long-term business strategy.
-
Devin O’Brien Coon, MD, MSE
President & Chief Medical OfficerDr. O’Brien Coon is President and Chief Medical Officer, guiding overall company development, clinical and business strategy, and R&D.
-
John Berry
Vice President of Sales & MarketingMr. Berry has worked with start-up, emerging, and world class companies including Moore, Steris, Salient Surgical, and Medtronic.
-
Michelle Zwernemann
Vice President of Operations, Quality, & StrategyMichelle Zwernemann, MSE, is a biomedical engineer with over 10 years of experience in medical device development and commercialization
-
Xin “Ben” Kang
Director of Research & DevelopmentDr. Xin (Ben) Kang is Director of Research and Development, overseeing research and product development in addition to invention and exploration of new projects.
-
Gerry Buss
Director of Regulatory AffairsMr. Buss has over 25 years of experience in the medical device industry directing quality and regulatory affairs programs for global companies, including over 20 years with GE Healthcare.
-
Tom Wojeck
Engineering ManagerTom Wojeck is a Software Engineer with over 25 years of experience in the software industry including 12 years in the medical device field.
Board of directors
-
Bill Niland
Mr. Niland joined Harpoon Medical as its president and CEO in 2014 and has since sold the company to Edwards Lifesciences for $100M upfront and up to $250M overall.
-
Bob Hallenbeck
Mr. Hallenbeck has spent over 30 years working with inventors, entrepreneurs and university tech transfer offices in developing, funding, licensing and commercializing technology.
-
Jerry Prince, PhD
Dr. Prince is the William B. Kouwenhoven Professor of Computer Engineering, Radiology and Biomedical Engineering at Johns Hopkins University.
-
David Narrow
Mr. Narrow previously worked with multinational medical device companies to commercialize their technologies and provide long-term business strategy.
-
Devin O’Brien-Coon, MD, MSE
Dr. O’Brien Coon is President and Chief Medical Officer, guiding overall company development, clinical and business strategy, and R&D.